(Q43252111)

English

Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study

scientific article published on 30 October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

cerebral blood flow

0 references

1 reference

based on heuristic

inferred from title

author name string

Masaki Watanabe

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Teruyuki Hirano

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sadahisa Okamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Shinya Shiraishi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Seiji Tomiguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Makoto Uchino

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

30 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

43-48

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

21 January 2018

Cerebral autoregulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

21 January 2018

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine lowers blood pressure without significant effect on cerebral blood flow in hypertensive patients with a history of stroke: a quantitative single photon emission computed tomography study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of nitrendipine on the autoregulation of regional cerebral blood flow in the pithed rabbit.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine, a Ca2+ channel antagonist, modifies cerebral blood flow autoregulation in hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of benidipine, a long-lasting dihydropyridine-Ca2+ channel blocker, on cerebral blood flow autoregulation in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the cerebral circulation: role of endothelium and potassium channels

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral circulation under normal and pathologic conditions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Aging and cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.179

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2009.179

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43252111&oldid=2205909507"